Dr. Hartmut Ehrlich, CEO, Abivax 00:00:00
Abivax CEO Dr. Hartmut Ehrlich talks about the progress and next development steps for its lead clinical-stage molecule against HIV.
Abivax CEO Dr. Hartmut Ehrlich talks about the progress and next development steps for its lead clinical-stage molecule against HIV.